Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandhya Chipurupalli

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Frontiers in Medicine|November 22, 2021
Crosstalk Between ER Stress, Autophagy and InflammationSandhya Chipurupalli, Unni Samavedam, Nirmal Robinson
Methods in Molecular Biology (Clifton, N.J.)|July 22, 2022
Analysis of ER-Phagy in Cancer Drug ResistanceSandhya Chipurupalli, Vincenzo Desiderio, Nirmal Robinson
International Journal of Molecular Sciences|February 14, 2019
Hypoxia Induced ER Stress Response as an Adaptive Mechanism in CancerSandhya Chipurupalli, Elango Kannan, Vinay Tergaonkar, et al.
Journal of Pharmacological and Toxicological Methods|October 22, 2020
Caenorhabditis elegans as a possible model to screen anti-Alzheimer's therapeuticsDeepraj Paul, Sandhya Chipurupalli, Antony Justin, et al.
Cell Death & Disease|February 20, 2025
Inactivation of necroptosis-promoting protein MLKL creates a therapeutic vulnerability in colorectal cancer cellsPeijia Jiang, Sandhya Chipurupalli, Byong Hoon Yoo, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|September 1, 2023
Natural tyrosinase enzyme inhibitors: A path from melanin to melanoma and its reported pharmacological activitiesRajan Logesh, Sagar Rajendra Prasad, Sandhya Chipurupalli, et al.
Frontiers in Oncology|June 2, 2020
Pharmacological STING Activation Is a Potential Alternative to Overcome Drug-Resistance in MelanomaSandhya Chipurupalli, Raja Ganesan, S P Dhanabal, et al.
Cell Death & Disease|September 1, 2023
Three-dimensional growth sensitizes breast cancer cells to treatment with ferroptosis-promoting drugsSandhya Chipurupalli, Peijia Jiang, Xiaoyang Liu, et al.
Cell Communication and Signaling : CCS|May 13, 2025
ER stress and/or ER-phagy in drug resistance? Three coincidences are proofSameer Kumar Panda, Ibone Rubio Sanchez-Pajares, Ayesha Rehman, et al.
Cell Death & Disease|August 6, 2022
ErbB2/Her2-dependent downregulation of a cell death-promoting protein BLNK in breast cancer cells is required for 3D breast tumor growthXiaoyang Liu, Sandhya Chipurupalli, Peijia Jiang, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Medicine|November 22, 2021
Crosstalk Between ER Stress, Autophagy and InflammationSandhya Chipurupalli, Unni Samavedam, Nirmal Robinson
Methods in Molecular Biology (Clifton, N.J.)|July 22, 2022
Analysis of ER-Phagy in Cancer Drug ResistanceSandhya Chipurupalli, Vincenzo Desiderio, Nirmal Robinson
International Journal of Molecular Sciences|February 14, 2019
Hypoxia Induced ER Stress Response as an Adaptive Mechanism in CancerSandhya Chipurupalli, Elango Kannan, Vinay Tergaonkar, et al.
Journal of Pharmacological and Toxicological Methods|October 22, 2020
Caenorhabditis elegans as a possible model to screen anti-Alzheimer's therapeuticsDeepraj Paul, Sandhya Chipurupalli, Antony Justin, et al.
Cell Death & Disease|February 20, 2025
Inactivation of necroptosis-promoting protein MLKL creates a therapeutic vulnerability in colorectal cancer cellsPeijia Jiang, Sandhya Chipurupalli, Byong Hoon Yoo, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|September 1, 2023
Natural tyrosinase enzyme inhibitors: A path from melanin to melanoma and its reported pharmacological activitiesRajan Logesh, Sagar Rajendra Prasad, Sandhya Chipurupalli, et al.
Frontiers in Oncology|June 2, 2020
Pharmacological STING Activation Is a Potential Alternative to Overcome Drug-Resistance in MelanomaSandhya Chipurupalli, Raja Ganesan, S P Dhanabal, et al.
Cell Death & Disease|September 1, 2023
Three-dimensional growth sensitizes breast cancer cells to treatment with ferroptosis-promoting drugsSandhya Chipurupalli, Peijia Jiang, Xiaoyang Liu, et al.
Cell Communication and Signaling : CCS|May 13, 2025
ER stress and/or ER-phagy in drug resistance? Three coincidences are proofSameer Kumar Panda, Ibone Rubio Sanchez-Pajares, Ayesha Rehman, et al.
Cell Death & Disease|August 6, 2022
ErbB2/Her2-dependent downregulation of a cell death-promoting protein BLNK in breast cancer cells is required for 3D breast tumor growthXiaoyang Liu, Sandhya Chipurupalli, Peijia Jiang, et al.
Pageof 2